Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿雷生物制药有限公司, Astrazeneca AbfiledCritical阿雷生物制药有限公司
Priority claimed from PCT/US2006/061895external-prioritypatent/WO2007076245A2/en
Publication of HK1124043A1publicationCriticalpatent/HK1124043A1/zh
Publication of HK1124043BpublicationCriticalpatent/HK1124043B/zh
Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer
(2-hydroksyetoksy)amid kwasu 6-(4-bromo-2-chlorofenyloamino)- 7-fluoro-3-metylo-3H-benzimidazolo-5-karboksylowego, zawierająca ten związek kompozycja farmaceutyczna oraz ich zastosowanie